Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Patient-Reported Treatment Experience with Oral Rivaroxaban: Results from the Noninterventional XALIA Study of Deep-Vein ThrombosisStefan Cano, Lorenzo Mantovani, Kerstin Folkerts, et al.The Journal of Clinical Investigation|June 3, 2009
The natriuretic peptide/guanylyl cyclase--a system functions as a stress-responsive regulator of angiogenesis in miceMichaela Kuhn, Katharina Völker, Kristine Schwarz, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|July 21, 2009
The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in miceNorbert Weissmann, Sascha Hackemack, Bhola Kumar Dahal, et al.BMJ Open|March 8, 2017
Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registryA John Camm, Gabriele Accetta, Wael Al Mahmeed, et al.Circulation. Cardiovascular Interventions|February 2, 2019
Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary InterventionMathieu Kerneis, Megan K Yee, Roxana Mehran, et al.European Heart Journal|December 28, 2017
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registryFreek W A Verheugt, Haiyan Gao, Wael Al Mahmeed, et al.Circulation. Cardiovascular Interventions|November 12, 2019
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI TrialMathieu Kerneis, Megan K Yee, Roxana Mehran, et al.The New England Journal of Medicine|December 14, 2016
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCIC Michael Gibson, Roxana Mehran, Christoph Bode, et al.American Heart Journal|July 18, 2018
Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trialGerald Chi, Mathieu Kerneis, Arzu Kalayci, et al.Journal of Thrombosis and Thrombolysis|June 27, 2018
Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary interventionGerald Chi, Megan K Yee, Arzu Kalayci, et al.Pageof 6